Vault Bioventures was hired to conduct a commercial and clinical assessment of a novel, phase III product, with a goal of maximizing portfolio value through a licensing deal.

Following our integrated product assessment, we identified and proposed a go to market strategy that would provide significant incremental value to the client. Our recommendations were adopted by Senior Management which led to a successful licensing deal.